Skip to content

A- or higher at other companies

BK
BKBK
1+1.0%
BK
BKBK
0
Phillips 66 logo
Phillips 66PSX
$827M+209%
Two Harbors Investment Corporation logo
Two Harbors Investment CorporationTWO
$13.66B-32.9%
M&T Bank logo
M&T BankMTB
$371.83M
Dow logo
DowDOW
$67M-40.7%

Other financials

Income statement

See full
Revenue$2.0B+26.6%
Gross profit$2.0B+28.1%
Net income$159.3M+16.4%
EPS (diluted)$0.70+22.8%

Balance sheet

See full
Cash & equivalents$13.7B+10.1%
Total debt$19.1B+20.0%
Total equity$10.6B+4.0%
Total assets$74.4B+5.9%

Cash flow

See full
Operating cash flow-$1.7B+34.8%
CapEx$64.9M+30.8%
Free cash flow-$1.8B+33.6%

Valuation

See full
Market cap$12.7B-32.8%
Enterprise value$18.13B-14.8%
P/E18×-9.1×
P/S1.6×-1.1×

Profitability

See full
Gross margin97.7%+0.8pp
Net margin9.1%-1.0pp
FCF margin17.6%+15.6pp

Returns & leverage

See full
Return on equity6.8%-0.2pp
Debt / equity1.8×+0.2×

Where this comes from

Reported directly by Jefferies Financial Group in its filing.

Tagged under the XBRL concept jef:FairValueOfOverCounterDerivativesAssetsCounterpartyCreditQualityAOrHigher.

The official record: Jefferies Financial Group’s 10-Q, filed April 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jefferies Financial Group's a- or higher.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jefferies Financial Group's a- or higher?
Jefferies Financial Group (JEF) reported a- or higher of $180.38M in Q4 2025.
How has Jefferies Financial Group's a- or higher changed year-over-year?
Jefferies Financial Group's a- or higher increased by 5.9% year-over-year, from $170.33M to $180.38M.
What does a- or higher mean?
The value of OTC derivative assets held with highly-rated counterparties (A- or better).
How do you interpret a- or higher?
Higher values indicate a safer, higher-quality counterparty credit profile.
How does a- or higher compare across companies?
Standard credit risk disclosure for financial institutions with significant OTC derivative exposure.